Invention Grant
- Patent Title: Pyridopyrazines and the use thereof as kinase inhibitors
- Patent Title (中): 吡啶并吡嗪类及其作为激酶抑制剂的用途
-
Application No.: US11825200Application Date: 2007-07-05
-
Publication No.: US08193186B2Publication Date: 2012-06-05
- Inventor: Irene Seipelt , Ulf R. Rapp , Ludmilla Wixler , Eckhard Claus , Eckhard Günther
- Applicant: Irene Seipelt , Ulf R. Rapp , Ludmilla Wixler , Eckhard Claus , Eckhard Günther
- Applicant Address: DE Frankfurt am Main
- Assignee: AEterna Zentaris GmbH
- Current Assignee: AEterna Zentaris GmbH
- Current Assignee Address: DE Frankfurt am Main
- Agency: Goodwin Procter LLP
- Priority: DE10323345 20030523
- Main IPC: A01N43/58
- IPC: A01N43/58 ; A01N43/60 ; A61K31/50 ; A61K31/495
Abstract:
The invention relates to novel pyrido[2,3-b]pyrazine derivatives of the general Formula I, their preparation and use as medicaments, in particular for the treatment of malignant and other disorders based on pathological cell proliferations.
Public/Granted literature
- US20070275972A1 Pyridopyrazines and the use thereof as kinase inhibitors Public/Granted day:2007-11-29
Information query
IPC分类:
